{"SPADE_N_07284": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07284", "Peptide Name": "TAT-cysteine peptide", "Source": "Protein derived", "Family": "", "Gene": "Not found", "Sequence": "AYGRKKRRQRRR", "Sequence Length": 12, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C67H123N33O15", "Mass": 1630.91, "PI": 12.0, "Net Charge": 8, "Hydrophobicity": -3.18, "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.", "Pubmed ID": "24709209", "Reference": "Int J Pharm. 2014 Jul 1;468(1-2)26-38.", "Author": "Mei L, Fu L, Shi K, Zhang Q, Liu Y, Tang J, Gao H, Zhang Z, He Q.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=24709209"}], "Frequent Amino Acids": "RKA", "Absent Amino Acids": "CDEFHILMNOPSTUVW", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 11, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_07343", "Similarity": 1.0, "Sequence": "CAYGRKKRRQRRR"}, {"SPADE_ID": "SPADE_UN_17288", "Similarity": 1.0, "Sequence": "WELVVAYGRKKRRQRRR"}, {"SPADE_ID": "SPADE_UN_17290", "Similarity": 1.0, "Sequence": "WEAVVAYGRKKRRQRRR"}]}}}